“Metabolic effects of LB03002, a sustained release formulation of rhGH, in children with GH Deficiency” are presented at ESPE 2012 in Leipzig, Germany.

Biopartners GmbH and LG Life Sciences Ltd present positive results from their phase III paediatric trial “Metabolic effects of LB03002, a sustained release formulation of rhGH, in children with GH Deficiency” at ESPE 2012 in Leipzig, Germany.

Please click here to read more